Kapur et al reported criteria for determining the stage of cardiogenic shock. The authors are from multiple institutions in the United States.
Patient selection: cardiogenic shock
Stage |
Society of Cardiovascular Angiography and Intervention (SCAI) |
SCAI and Cardiogenic Shock Working Group |
A |
hemodynamically stable |
hemodynamically stable |
B |
hemodynamically unstable |
hypotensive and hypoperfusing and untreated |
C |
hypoperfusion = shock |
hypotensive and hypoperfusing or treated |
D |
failure to stabilize with initial therapy |
failure to stabilize with initial therapy |
E |
in extremis; refractory shock |
in extremis; refractory shock |
Parameters:
(1) systolic blood pressure
(2) diastolic blood pressure
(3) serum lactate in mmol/L
(4) serum ALT in IU
(5) arterial pH
(6) number of vasoactive and inotropic drugs
(7) number of circulatory support devices
(8) persistent hypotension or hypoperfusion
(9) out of hospital cardiac arrest
mean arterial pressure in mm Hg =
= ((systolic blood pressure) + (2 * (diastolic blood pressure))) / 3
total number drugs and devices =
= (number of vasoactive drugs) + (number of circulatory support drugs)
Stage |
BP |
lactate |
ALT |
pH |
Drug/Device |
B |
MAP 50-65 |
< 2 |
< 200 |
>= 7.2 |
none |
B |
MAP > 65 |
2-5 |
< 200 |
>= 7.2 |
none |
B |
MAP > 65 |
<2 |
200-500 |
>= 7.2 |
none |
C |
MAP 50-65 |
2-5 |
< 200 |
>= 7.2 |
none |
C |
MAP 50-65 |
< 2 |
200-500 |
>= 7.2 |
none |
C |
NA |
NA |
NA |
NA |
1 or 1 sans |
D |
MAP 50-65 |
5.01-10 |
<= 500 |
>= 7.2 |
<3 and <3 |
D |
MAP 50-65 |
<= 5 |
> 500 |
>= 7.2 |
<3 and <3 |
D |
NA |
NA |
NA |
NA |
1 or 1 with |
D |
NA |
NA |
NA |
NA |
2 to 5 |
E |
MAP < 50 |
NA |
NA |
NA |
NA |
E |
NA |
> 10 |
NA |
NA |
NA |
E |
NA |
NA |
NA |
< 7.2 |
NA |
E |
NA |
NA |
NA |
NA |
>= 3 Drugs |
E |
NA |
NA |
NA |
NA |
>= 3 Dev |
E |
NA |
NA |
NA |
NA |
see note |
An out-of-hospital cardiac arrest was also Stage E.
Specialty: Pulmonology, Critical Care